United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
25.67%
↓ 63% below average
Average (9y)
68.54%
Historical baseline
Range
High:587.45%
Low:-117.65%
CAGR
-14.1%
Structural decline
| Period | Value |
|---|---|
| 2024 | 25.67% |
| 2023 | 31.66% |
| 2022 | 50.75% |
| 2021 | -9.01% |
| 2020 | 587.45% |
| 2019 | -117.65% |
| 2018 | 42.53% |
| 2017 | -41.68% |
| 2016 | 14.96% |
| 2015 | 100.71% |